Detalhe da pesquisa
1.
Clinicopathological features and resistance mechanisms in HIP1-ALK-rearranged lung cancer: A multicenter study.
Genes Chromosomes Cancer
; 61(4): 177-186, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34687488
2.
The prognostic impact of immune checkpoint inhibitors for the treatment of pulmonary sarcomatoid carcinoma: A multicenter retrospective study.
Neoplasma
; 69(6): 1437-1444, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36353935
3.
Potential mechanism of primary resistance to icotinib in patients with advanced non-small cell lung cancer harboring uncommon mutant epidermal growth factor receptor: A multi-center study.
Cancer Sci
; 111(2): 679-686, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31828849
4.
Ginsenoside compound K inhibits growth of lung cancer cells via HIF-1α-mediated glucose metabolism.
Cell Mol Biol (Noisy-le-grand)
; 65(4): 48-52, 2019 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31078152
5.
Simultaneous VENTANA IHC and RT-PCR testing of ALK status in Chinese non-small cell lung cancer patients and response to crizotinib.
J Transl Med
; 16(1): 93, 2018 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29642919
6.
MiR-33b inhibits osteosarcoma cell proliferation through suppression of glycolysis by targeting Lactate Dehydrogenase A (LDHA).
Cell Mol Biol (Noisy-le-grand)
; 64(11): 31-35, 2018 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30213286
7.
Knockdown of MPP8 suppresses cell proliferation via regulation of HOXA5 in non-small cell lung cancer cells.
Cell Mol Biol (Noisy-le-grand)
; 64(1): 27-31, 2018 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29412790
8.
Association between BIM polymorphism and lung cancer outcomes: a meta-analysis.
Cell Mol Biol (Noisy-le-grand)
; 64(11): 92-96, 2018 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30213299
9.
A meta-analysis of association between serum iron levels and lung cancer risk.
Cell Mol Biol (Noisy-le-grand)
; 64(13): 33-37, 2018 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30403607
10.
Combined detection of CEA and CA125 for the diagnosis for lung cancer: A meta-analysis.
Cell Mol Biol (Noisy-le-grand)
; 64(15): 67-70, 2018 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30672447
11.
OTX1 Contributes to Hepatocellular Carcinoma Progression by Regulation of ERK/MAPK Pathway.
J Korean Med Sci
; 31(8): 1215-23, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27478331
12.
Response and acquired resistance to MET inhibitors in de novo MET fusion-positive advanced non-small cell lung cancer.
Lung Cancer
; 178: 66-74, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36806896
13.
D-1553 (Garsorasib), a Potent and Selective Inhibitor of KRASG12C in Patients With NSCLC: Phase 1 Study Results.
J Thorac Oncol
; 18(7): 940-951, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36948246
14.
S1PR1 regulates ovarian cancer cell senescence through the PDK1-LATS1/2-YAP pathway.
Oncogene
; 42(47): 3491-3502, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37828220
15.
CpG-binding protein CFP1 promotes ovarian cancer cell proliferation by regulating BST2 transcription.
Cancer Gene Ther
; 29(12): 1895-1907, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35864225
16.
Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis.
NPJ Precis Oncol
; 6(1): 66, 2022 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36123526
17.
Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
Open Med (Wars)
; 16(1): 169-174, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33585692
18.
A real-world study in advanced non-small cell lung cancer with de novo brain metastasis.
J Cancer
; 12(5): 1467-1473, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33531991
19.
An insertion mutation of ERBB2 enhances breast cancer cell growth and confers resistance to lapatinib through AKT signaling pathway.
Biol Open
; 9(1)2020 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31980423
20.
Treatment and prognosis of primary malignant melanoma of the esophagus.
Transl Cancer Res
; 9(7): 4141-4147, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35117783